1. Changes in treatment practices spur rise in chemo-related AML

   Epidemiology population study 02 March 2013 Pages: 1 - 1

2. Pulmonary toxicity warning stengthened on docetaxel label

   Review 02 March 2013 Pages: 2 - 2

3. Post-op codeine use in children, new Boxed Warning

   News item 02 March 2013 Pages: 2 - 2

4. PROTECT project launches two new databases

   Media release 02 March 2013 Pages: 2 - 2

5. Anaemia drug recalled following reports of anaphylaxis

   News item 02 March 2013 Pages: 2 - 2

6. Rivaroxaban of no net clinical benefit in critically ill patients

   Clinical study 02 March 2013 Pages: 3 - 3

7. Ascorbic acid supplements increase kidney stone risk

   Incidence study 02 March 2013 Pages: 3 - 3

8. Influenza A/H1N1 MF59 adjuvanted vaccine safe during pregnancy

   Epidemiology population study 02 March 2013 Pages: 3 - 3

9. Long-acting opioids increase the risk of hypogonadism in men

   Incidence study 02 March 2013 Pages: 3 - 3

10. FDA promotes campaign against substandard, counterfeit meds

    Review 02 March 2013 Pages: 4 - 4

11. REMS lack data, according to US Inspector General

    Review 02 March 2013 Pages: 4 - 4

12. PMDA surveys Japan hospitals' use of drug safety info

    News item 02 March 2013 Pages: 4 - 4

13. Adalimumab/infliximab

    Case report 02 March 2013 Pages: 5 - 5

14. Adalimumab

    Case report 02 March 2013 Pages: 5 - 5

15. Abacavir/stavudine

    Case report 02 March 2013 Pages: 5 - 5

16. Alendronic acid

    Case report 02 March 2013 Pages: 5 - 5

17. Amoxicillin/fluoroquinolones

    Case report 02 March 2013 Pages: 6 - 6

18. Amlodipine/duloxetine/rosuvastatin/sertraline interaction

    Case report 02 March 2013 Pages: 6 - 6

19. Anakinra

    Case report 02 March 2013 Pages: 6 - 6

20. Antibacterials/diclofenac/furosemide

    Case report 02 March 2013 Pages: 6 - 6

21. Antineoplastics/diuretics/filgrastim/methylprednisolone

    Case report 02 March 2013 Pages: 7 - 7

22. Antipsychotics

    Case report 02 March 2013 Pages: 7 - 7

23. Antihypertensives/anxiolytics/lithium interaction

    Case report 02 March 2013 Pages: 7 - 7

24. Antiretrovirals/escitalopram/esomeprazole interaction

    Case report 02 March 2013 Pages: 8 - 8

25. Aripiprazole

    Case report 02 March 2013 Pages: 8 - 8

26. Arachis hypogaea oil

    Case report 02 March 2013 Pages: 8 - 8

27. Antithymocyte globulin

    Case report 02 March 2013 Pages: 8 - 8

28. Aripiprazole

    Case report 02 March 2013 Pages: 9 - 9

29. Aripiprazole/olanzapine/risperidone

    Case report 02 March 2013 Pages: 9 - 9

30. Aspirin/heparin/prednisolone

    Case report 02 March 2013 Pages: 9 - 9

31. Aripiprazole

    Case report 02 March 2013 Pages: 9 - 9

32. Azithromycin/methadone interaction

    Case report 02 March 2013 Pages: 10 - 10

33. Atomoxetine

    Case report 02 March 2013 Pages: 10 - 10

34. Bemiparin sodium/heparin

    Case report 02 March 2013 Pages: 10 - 10

35. Bevacizumab

    Case report 02 March 2013 Pages: 11 - 11

36. Butalbital/paracetamol/caffeine overdose

    Case report 02 March 2013 Pages: 11 - 11

37. Bevacizumab

    Case report 02 March 2013 Pages: 11 - 11

38. Bupropion/citalopram/tramadol interaction

    Case report 02 March 2013 Pages: 11 - 11

39. Cyclopentolate/phenylephrine

    Case report 02 March 2013 Pages: 12 - 12

40. Capecitabine

    Case report 02 March 2013 Pages: 12 - 12

41. Cefuroxime axetil

    Case report 02 March 2013 Pages: 12 - 12

42. Cabergoline

    Case report 02 March 2013 Pages: 12 - 12

43. Diazepam

    Case report 02 March 2013 Pages: 13 - 13

44. Dibotermin-α

    Case report 02 March 2013 Pages: 13 - 13

45. Cytarabine/daunorubicin/etoposide

    Case report 02 March 2013 Pages: 13 - 13

46. DTaP-hepatitis B-poliovirus vaccine/pneumococcal 7-valent vaccine

    Case report 02 March 2013 Pages: 14 - 14

47. Docetaxel

    Case report 02 March 2013 Pages: 14 - 14

48. Duloxetine/warfarin interaction

    Case report 02 March 2013 Pages: 14 - 14

49. Docetaxel

    Case report 02 March 2013 Pages: 14 - 14

50. Eptifibatide

    Case report 02 March 2013 Pages: 15 - 15